CN1308025C - Medicine for treating paraplegia and its preparing method - Google Patents
Medicine for treating paraplegia and its preparing method Download PDFInfo
- Publication number
- CN1308025C CN1308025C CNB2005100513978A CN200510051397A CN1308025C CN 1308025 C CN1308025 C CN 1308025C CN B2005100513978 A CNB2005100513978 A CN B2005100513978A CN 200510051397 A CN200510051397 A CN 200510051397A CN 1308025 C CN1308025 C CN 1308025C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma atractylodis
- paraplegia
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 206010033892 Paraplegia Diseases 0.000 title claims abstract description 21
- 229940079593 drug Drugs 0.000 title claims description 15
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 15
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 15
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims description 25
- 241001550206 Colla Species 0.000 claims description 14
- 241000209020 Cornus Species 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 14
- 241000237903 Hirudo Species 0.000 claims description 14
- 239000009636 Huang Qi Substances 0.000 claims description 14
- 241000283956 Manis Species 0.000 claims description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 3
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 3
- 241001330002 Bambuseae Species 0.000 claims description 3
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 3
- 239000011425 bamboo Substances 0.000 claims description 3
- 239000012188 paraffin wax Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 210000004185 liver Anatomy 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 11
- 238000005728 strengthening Methods 0.000 abstract description 7
- 230000003213 activating effect Effects 0.000 abstract description 6
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 210000001032 spinal nerve Anatomy 0.000 abstract 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000233890 Alisma plantago Species 0.000 abstract 1
- 235000017300 Alisma plantago Nutrition 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000006264 Asimina triloba Nutrition 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 244000131360 Morinda citrifolia Species 0.000 abstract 1
- 235000008898 Morinda citrifolia Nutrition 0.000 abstract 1
- 235000008248 Morinda citrifolia var citrifolia Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 201000010934 exostosis Diseases 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 201000010930 hyperostosis Diseases 0.000 abstract 1
- 235000017524 noni Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 33
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 12
- 210000003205 muscle Anatomy 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000003387 muscular Effects 0.000 description 6
- 210000003141 lower extremity Anatomy 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 229940126678 chinese medicines Drugs 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010021118 Hypotonia Diseases 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- -1 flavone compound Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 210000000278 spinal cord Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 230000005251 gamma ray Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 239000000899 Gutta-Percha Substances 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 240000000342 Palaquium gutta Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229920000588 gutta-percha Polymers 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a medicine for treating paraplegia caused by damaged spinal nerves. The medicine prepared from milkvetch root, rhizoma, water plantain, dried tangerine peel, tuckahoe, coix seed, peach seed, safflower, pangolin scale, suberect spatholobus, notoginseng, Chinese taxillus twig, achyranthes, leech, cassia twig, kudzuvine root, eucommia bark, medicinal indianmulberry root, deerhorn glue, white peony alba, cornel, pawpaw, ledebouriella root and atractylodes rhizome has the functions of nourishing the liver and the kidney, strengthening essence, increasing pith, supplementing Qi, activating blood circulation, dredging channels and activating nerves, and has the favorable efficiency of treating paraplegia caused damaged spinal nerves, various kinds of hyperostosis and various kinds of spondylodynia.
Description
Technical field:
The present invention relates to medicine of the paraplegia that a kind of neurologic defict causes and preparation method thereof, belong to technical field of Chinese medicines.
Background technology:
Spinal cord is positioned at intraspinal last 2/3.Spinal cord is neural rudimentary part, the influence of its active receiving high-level center, and its sophisticated functions of finishing is subjected to control, the adjusting of brain, so it has reflection function (as quadriceps reflex) and conduction function.Paraplegia is exactly causedly after the spinal cord injury that causes of a variety of causes to think the afunction of the corresponding part or all of trunk of two lower limb or a kind of disease of reduction with nerve injury.Paraplegia has been brought inconvenience to the live and work of extensive patients and family numbers of patients.And according to investigations, there is not a kind of medicine for the treatment of the paraplegia that neurologic defict causes in the market.
Summary of the invention
Neurologic defict is the result who occurs obstacle owing to ischemia of spinal cord, blood supply; And paraplegia is because of after a variety of causes causes, causes that the QI and blood what stagnates, deficiency of both the liver and kidney, wind and cold obstruction of meridian meridians are obstructed the hepatic and renal YIN deficiency, the deficiency of spleen-YANG and kidneyYANG of causing of a specified duration.Chinese medicine is thought: the unification of world human body, forked rubbing, the negative and positive that natural all variations directly influence human body change, neurologic defict must influence the normal function of human five internal organs's six internal organs, thereby cause coagulation of QI-blood, prolonged illness then void then cause deficiency of both the liver and kidney, immune function of human body is low, the wind and cold damp-phlegm stops passages through which vital energy circulates, and the paraplegia symptom that occurs.Therefore in treatment, adopt nourishing the liver and kidney, strong essence to increase the principle of marrow, activating blood circulation and supplementing qi, dredge the meridian passage, make muscles and bones be able to strong, function and recovered.
In order to make the paralyses patient can early recovery, the inventor be based on theory of Chinese medical science, from Chinese crude drug, chosen have nourishing the liver and kidney, essence increases marrow, activating blood circulation and supplementing qi, dredge the meridian passage effect by force Chinese crude drug, make medicine of the present invention.
The objective of the invention is to disclose a kind of Chinese medicinal components for the treatment of the medicine of the paraplegia that neurologic defict causes.
Another object of the present invention is to provide the preparation method of this medicine.
Medicine of the present invention is chosen 24 kinds of Chinese medicines and is made up, and these 24 kinds of Chinese medicines are made up of the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis, Pericarpium Citri Reticulatae, Poria, Semen Coicis, Semen Persicae, Flos Carthami, Squama Manis, Caulis Spatholobi, Radix Notoginseng, Herba Taxilli, river Niu Xi, Hirudo, Ramulus Cinnamomi, Radix Puerariae, the Cortex Eucommiae, Radix Morindae Officinalis, Colla cornus cervi, the Radix Paeoniae Alba, Fructus Corni, Fructus Chaenomelis, Radix Saposhnikoviae, Rhizoma Atractylodis.
The inventor has determined that the amount ranges of each component of medicine of the present invention is as follows through constantly groping:
Radix Astragali 15g-100g, Rhizoma Atractylodis Macrocephalae 6g-25g, Rhizoma Alismatis 4g-30g, Pericarpium Citri Reticulatae 3g-20g, Poria 3g-30g, Semen Coicis 3g-30g, Semen Persicae 5g-45g, Flos Carthami 3g-30g, Squama Manis 1g-20g, Caulis Spatholobi 10g-100g, Radix Notoginseng 2g-50g, Herba Taxilli 4g-35g, river cattle sunset 6g-50g, Hirudo 4g-40g, Ramulus Cinnamomi 1.5g-40g, Radix Puerariae 4g-60g, Cortex Eucommiae 6g-40g, Radix Morindae Officinalis 6g-40g, Colla cornus cervi 1.5g-20g, Radix Paeoniae Alba 8g-70g, Fructus Corni 6g-50g, Fructus Chaenomelis 4g-50g, Radix Saposhnikoviae 1.5g-30g, Rhizoma Atractylodis 4g-30g.
Wherein the preferred weight ratio range of each crude drug is: Radix Astragali 30g-90g, Rhizoma Atractylodis Macrocephalae 10g-20g, Rhizoma Alismatis 10g-20g, Pericarpium Citri Reticulatae 5g-20g, Poria 8g-20g, Semen Coicis 8g-20g, Semen Persicae 15g-35g, Flos Carthami 5g-20g, Squama Manis 5g-20g, Caulis Spatholobi 20g-80g, Radix Notoginseng 10g-40g, Herba Taxilli 10g-30g, river cattle sunset 10g-40g, Hirudo 8g-35g, Ramulus Cinnamomi 5g-30g, Radix Puerariae 10g-50g, Cortex Eucommiae 10g-30g, Radix Morindae Officinalis 10g-30g, Colla cornus cervi 8g-20g, Radix Paeoniae Alba 10g-60g, Fructus Corni 10g-45g, Fructus Chaenomelis 10g-40g, Radix Saposhnikoviae 10g-25g, Rhizoma Atractylodis 10g-30g.
Wherein the optimum weight ratio range of each crude drug is: Radix Astragali 45g-65g, Rhizoma Atractylodis Macrocephalae 10g-15g, Rhizoma Alismatis 10g-15g, Pericarpium Citri Reticulatae 10g-15g, Poria 10g-15g, Semen Coicis 15g-20g, Semen Persicae 15g-20g, Flos Carthami 10g-15g, Squama Manis 8g-12g, Caulis Spatholobi 40g-50g, Radix Notoginseng 15g-20g, Herba Taxilli 15g-25g, river cattle sunset 20g-30g, Hirudo 15g-25g, Ramulus Cinnamomi 10g-20g, Radix Puerariae 15g-30g, Cortex Eucommiae 15g-20g, Radix Morindae Officinalis 15g-25g, Colla cornus cervi 10g-15g, Radix Paeoniae Alba 40g-55g, Fructus Corni 10g-20g, Fructus Chaenomelis 15g-25g, Radix Saposhnikoviae 10g-15g, Rhizoma Atractylodis 15g-25g.
Wherein the optimum weight proportioning of each crude drug is: Radix Astragali 60g, Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Alismatis 15g, Pericarpium Citri Reticulatae 12g, Poria 12g, Semen Coicis 15g, Semen Persicae 20g, Flos Carthami 12g, Squama Manis 10g, Caulis Spatholobi 45g, Radix Notoginseng 20g, Herba Taxilli 20g, river cattle sunset 25g, Hirudo 20g, Ramulus Cinnamomi 15g, Radix Puerariae 20g, Cortex Eucommiae 15g, crust halberd 18g, Colla cornus cervi 10g, Radix Paeoniae Alba 50g, Fructus Corni 15g, Fructus Chaenomelis 20g, Radix Saposhnikoviae 13g, Rhizoma Atractylodis 20g.
The preparation method of medicine of the present invention is as follows:
(1), the described Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis, Pericarpium Citri Reticulatae, Poria, Semen Coicis, Semen Persicae, Flos Carthami, Squama Manis, Caulis Spatholobi, Radix Notoginseng, Herba Taxilli, river Niu Xi, Hirudo, Ramulus Cinnamomi, Radix Puerariae, the Cortex Eucommiae, Radix Morindae Officinalis, Colla cornus cervi, the Radix Paeoniae Alba, Fructus Corni, Fructus Chaenomelis, Radix Saposhnikoviae and Rhizoma Atractylodis are pulverized, then through 100 order square-bottomed bamboo baskets screenings, carry out behind the irradiation sterilization medicine fully being stirred evenly into powder with the gamma ray of cobalt-60;
(2), take the Mel after Coarse Mesh Gauze filters, be fried boiling with high heat, reuse slow fire is fried in shallow oil slowly, soaks buff on boiling to Mel;
(3), get in the step (1) Mel in the powder and step (2), stir evenly with 1000 gram powder and 1100 gram Mel proportionings, scoop up the bar pill with 6 gram pinch plates, paraffin paper seals, and packs.
In 24 kinds of Chinese medicines of choice of drug of the present invention:
Warm in nature, the sweet in the mouth of the Radix Astragali has tonifying Qi and lifting yang, benefit to defend the effect of consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, diuretic detumescent, and energy such as its contained main component glycoside, polysaccharide enhancing human body immunity function also has the repair of antibacterial action, acceleration damage body widely;
Warm in nature, the bitter but sweet flavor of the Rhizoma Atractylodis Macrocephalae has air making-up and spleen enlivening, dampness diuretic, strengthening superficial resistance to stop perspiration, antiabortive effect, and the main component atractylone in its oil, Rhizoma Atractylodis Macrocephalae lactone A, B and saccharide have strong, diuresis, anticoagulant effect;
Cold in nature, the slightly sweet flavor of Rhizoma Alismatis, the effect that promoting diuresis to eliminate damp pathogen is arranged, expels the heat-evil;
Pericarpium Citri Reticulatae is warm in nature, acrid in the mouth is bitter, in the reasonable controlled atmosphere, the effect of drying dampness to eliminate phlegm,
Poria is flat, slightly sweet flavor, and the effect of promoting diuresis to eliminate damp pathogen, invigorating spleen and reinforcing stomach, mind tranquilizing and the heart calming is arranged;
Semen Coicis cold nature, slightly sweet flavor have the effect of promoting diuresis to eliminate damp pathogen, arthralgia relieving by relaxing muscles and tendons, clearing away heat and discharging pus, and its oil can stop or reduce the effect of striped muscle contracture;
Semen Persicae is flat, sweet-bitter flavor, and the effect of blood circulation promoting and blood stasis dispelling, laxation relieving constipation is arranged, and its main component Semen Armeniacae Amarum glycoside has anticoagulant and more weak haemolysis, and blood flow prevention, the capable obstacle of blood are had the improvement effect;
Warm in nature, the acrid in the mouth of Flos Carthami has the effect of promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain, its main component carthamin that anticoagulant is arranged and increases the fibrinolytic effect;
Squama Manis cold nature, salty in the mouth have the effect of promoting blood circulation to restore menstrual flow, stimulating milk secretion, detumescence and apocenosis, can declare logical internal organs, implement meridians, reach the pass key thoroughly, are used for blood clotting, the poly-disease of blood;
Warm in nature, the bitter but slightly sweet taste of Caulis Spatholobi has that promoting the circulation of blood is enriched blood, the effect of relaxing muscles and tendons and activating QI and blood in the collateral, and its Main Ingredients and Appearance milletol has antiinflammatory action to fibrin;
Hirudo property is flat, salty in the mouth is bitter, and the effect of removing blood stasis, blood fat reducing is arranged, and its main component hirudin can stop thrombin to fibrinous effect, hinders blood coagulation;
Warm in nature, the sweet and slightly bitter taste of Radix Notoginseng has the effect of removing stasis to stop bleeding, promoting blood circulation and stopping pain, and its main component arasaponin, flavonoid glycoside etc. have remarkable anticoagulation, can anticoagulant, and promote fibrinolytic, and the blood clotting degree is descended;
Flat, the sweet and slightly bitter taste of river cattle sunset property has blood circulation promoting and blood stasis dispelling, tonifying liver and kidney and strengthening bones and muscles, inducing diuresis for treating stranguria syndrome, a descending effect of igniting, and its main component triterpenoid saponin has the effect that promotes that inflammatory swelling disappears;
Flat, the bitter in the mouth of Herba Taxilli natural disposition has wind-damp dispelling, tonifying liver and kidney and strengthening bones and muscles, antiabortive effect, and its main component flavone compound has inhibitory action to poliomyelitis;
Warm in nature, the acrid-sweet flavor of Ramulus Cinnamomi has the activate yang effect of gas, warming YANG to promote diuresis, temperature three-way meridian, warm promoting blood circulation of diaphoresis expelling pathogenic factors from muscles, temperature;
Radix Puerariae is cool in nature, sweet in the mouth is hot, and expelling pathogenic factors from muscles for reducing heat, treating measles, promoting the production of body fluid to quench thirst, yang invigorating antidiarrheal effect are arranged;
Fructus Chaenomelis sour in the mouth warm in nature has the effect of relaxing muscles and tendons and activating QI and blood in the collateral, removing dampness to restore normal function of the stomach, and its main component Saponin, flavone compound have obvious detumescence effect, relax the effect of limb muscle spasm arthritis;
Warm in nature, the sweet in the mouth of the Cortex Eucommiae has invigorating the liver and kidney, bone and muscle strengthening, antiabortive effect, and its main component gutta-percha, flavone compound have adrenal cortex reinforcing function, enhancing human body immunity power;
The Radix Morindae Officinalis slightly warm in nature, acrid in the mouth, sweet has the effect of reinforcing the kidney and supporting YANG, expelling wind and removing dampness;
Warm in nature, the sweet-salty of Colla cornus cervi has the effect of invigorating the liver and kidney, benefiting essence-blood, its main component pantocrine can promote body fertility growth, improves the ability to work of body;
Radix Paeoniae Alba cold nature, bitter in the mouth acid have the effect of nourishing blood for regulating menstruation, easing the affected liver to relieve pain, suppressing liver-YANG, astringing YIN to stop sweating, and its main component paeoniflorin has spasmolysis preferably;
Fructus Corni slightly warm in nature, sour in the mouth have liver and kidney tonifying, the astringent or styptic treatment for spontaneous sweating effect of convergence;
Radix Saposhnikoviae slightly warm in nature, acrid-sweet flavor have the effect of expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, and main all wind whole body is unsuccessful, joint is ached, the extremity contraction anxious, the flaccidity syndrome and arthralgia syndrome crick;
Warm in nature, the acrid-sweet flavor of Rhizoma Atractylodis has effect drying damp and strengthening spleen, expelling wind and removing dampness.
The Cortex Eucommiae, Radix Morindae Officinalis, Colla cornus cervi, Fructus Corni, Herba Taxilli, the river Niu Xiwei monarch drug of medicine of the present invention so that the nourishing liver and kidney effect to be arranged; With the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis, Poria, Semen Coicis, Rhizoma Atractylodis, Pericarpium Citri Reticulatae that spleen reinforcing yang invigorating effect is arranged is ministerial drug; With Semen Persicae, Flos Carthami, Squama Manis, Hirudo, Radix Notoginseng, Caulis Spatholobi that blood circulation invigorating efficacies is arranged is adjuvant drug; With Ramulus Cinnamomi, Radix Saposhnikoviae, Radix Puerariae, the Radix Paeoniae Alba, Fructus Chaenomelis that dispelling pathogenic wind from muscles is arranged is messenger drug, with Yin Yang balancing, logical merit of transferring the vital organs of the human body, activates the nerve of paralysis and damage, and the corresponding limbs of its damage location are recovered.
At present no a kind of medicine for the treatment of the paraplegia that neurologic defict causes on the market, medicine of the present invention prove by clinical trial, and to the paraplegia that is caused by neurologic defict, and various hyperosteogeny and various spondylopathy all have better curative effect.
The specific embodiment
Below by testing the beneficial effect that example illustrates that medicine of the present invention (to call " numbness flaccidity ball " in the following text) is had, this test example is the clinical efficacy test of medicine of the present invention
[test example]
1, physical data
Accept paralytic patient 1000 examples that cause by neurologic defict for medical treatment.
2, diagnostic criteria
Cervical vertebra: up and down muscular strength 0-2 level, gatism, paraplegia plane more than T3, limb muscle atrophy up and down;
Thoracic vertebra: lower-limb muscular strength 0-1 level, gatism, paraplegia plane more than L2, the lower limb muscles atrophy;
Lumbar vertebra: lower-limb muscular strength 0-1 level, gatism, paraplegia plane more than umbilicus, the lower limb muscles atrophy;
3, Therapeutic Method
Oral, three times on the one, one time one ball or follow the doctor's advice, two months is a course of treatment.
4, efficacy assessment standard
Cervical vertebra (C
3-C
7): oneself walking or need the people to assist in, need the people to help wheelchair up and down, oneself people's wheelchair is in indoor and outdoor activity or the frame walking aid of asking for an advance on one's pay walking, and muscular strength 2-4 level, with board and lodging exclusive, defecation are taken care of oneself to curing;
Thoracic vertebra (T
1-T
12): own independent ambulation or catch wheelchair, muscular strength 3-5 level, with board and lodging exclusive, defecation is taken care of oneself to curing;
Lumbar vertebra (L
1-L
5): own independent ambulation or catch wheelchair, muscular strength 3-5 level, with board and lodging exclusive, defecation is taken care of oneself to curing;
Various symptoms alleviate in various degree to taking a turn for the better;
Various symptoms do not have any be changed to invalid.
5, therapeutic outcome
1000 patients take three courses of treatment of numbness flaccidity ball, and therapeutic outcome is as follows:
Effective percentage 98.7% cure rate 68.4% inefficiency 1.3%
[embodiment]
(1), with described Radix Astragali 60g, Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Alismatis 15g, Pericarpium Citri Reticulatae 12g, Poria 12g, Semen Coicis 15g, Semen Persicae 20g, Flos Carthami 12g, Squama Manis 10g, Caulis Spatholobi 45g, Radix Notoginseng 20g, Herba Taxilli 20g, river cattle sunset 25g, Hirudo 20g, Ramulus Cinnamomi 15g, Radix Puerariae 20g, Cortex Eucommiae 15g, Radix Morindae Officinalis 18g, Colla cornus cervi 10g, Radix Paeoniae Alba 50g, Fructus Corni 15g, Fructus Chaenomelis 20g, Radix Saposhnikoviae 13g, Rhizoma Atractylodis 20g.Pulverize,, carry out behind the irradiation sterilization medicine fully being stirred evenly into powder with the gamma ray of cobalt-60 then through the screening of 100 order square-bottomed bamboo baskets;
(2), take the Mel after Coarse Mesh Gauze filters, be fried boiling with high heat, reuse slow fire is fried in shallow oil slowly, soaks buff on boiling to Mel;
(3), get in the step (1) Mel in the powder and step (2), stir evenly with 1000 gram powder and 1100 gram Mel proportionings, scoop up the bar pill with 6 gram pinch plates, paraffin paper seals, and packs.
Claims (5)
1, a kind of medicine for the treatment of paraplegia is characterized in that it is made up of following materials of weight proportions medicine: Radix Astragali 15g-100g, Rhizoma Atractylodis Macrocephalae 6g-25g, Rhizoma Alismatis 4g-30g, Pericarpium Citri Reticulatae 3g-20g, Poria 3g-30g, Semen Coicis 3g-30g, Semen Persicae 5g-45g, Flos Carthami 3g-30g, Squama Manis 1g-20g, Caulis Spatholobi 10g-100g, Radix Notoginseng 2g-50g, Herba Taxilli 4g-35g, Radix Cyathulae 6g-50g, Hirudo 4g-40g, Ramulus Cinnamomi 1.5g-40g, Radix Puerariae 4g-60g, Cortex Eucommiae 6g-40g, Radix Morindae Officinalis 6g-40g, Colla cornus cervi 1.5g-20g, Radix Paeoniae Alba 8g-70g, Fructus Corni 6g-50g, Fructus Chaenomelis 4g-50g, Radix Saposhnikoviae 1.5g-30g, Rhizoma Atractylodis 4g-30g.
2, a kind of medicine for the treatment of paraplegia according to claim 1, wherein the weight proportion of each crude drug is: Radix Astragali 30g-90g, Rhizoma Atractylodis Macrocephalae 10g-20g, Rhizoma Alismatis 10g-20g, Pericarpium Citri Reticulatae 5g-20g, Poria 8g-20g, Semen Coicis 8g-20g, Semen Persicae 15g-35g, Flos Carthami 5g-20g, Squama Manis 5g-20g, Caulis Spatholobi 20g-80g, Radix Notoginseng 10g-40g, Herba Taxilli 10g-30g, Radix Cyathulae 10g-40g, Hirudo 8g-35g, Ramulus Cinnamomi 5g-30g, Radix Puerariae 10g-50g, Cortex Eucommiae 10g-30g, Radix Morindae Officinalis 10g-30g, Colla cornus cervi 8g-20g, Radix Paeoniae Alba 10g-60g, Fructus Corni 10g-45g, Fructus Chaenomelis 10g-40g, Radix Saposhnikoviae 10g-25g, Rhizoma Atractylodis 10g-30g.
3, a kind of medicine for the treatment of paraplegia according to claim 1, wherein the weight proportion of each crude drug is: Radix Astragali 45g-65g, Rhizoma Atractylodis Macrocephalae 10g-15g, Rhizoma Alismatis 10g-15g, Pericarpium Citri Reticulatae 10g-15g, Poria 10g-15g, Semen Coicis 15g-20g, Semen Persicae 15g-20g, Flos Carthami 10g-15g, Squama Manis 8g-12g, Caulis Spatholobi 40g-50g, Radix Notoginseng 15g-20g, Herba Taxilli 15g-25g, Radix Cyathulae 20g-30g, Hirudo 15g-25g, Ramulus Cinnamomi 10g-20g, Radix Puerariae 15g-30g, Cortex Eucommiae 15g-20g, Radix Morindae Officinalis 15g-25g, Colla cornus cervi 10g-15g, Radix Paeoniae Alba 40g-55g, Fructus Corni 10g-20g, Fructus Chaenomelis 15g-25g, Radix Saposhnikoviae 10g-15g, Rhizoma Atractylodis 15g-25g.
4, a kind of medicine for the treatment of paraplegia according to claim 1, wherein the weight proportion of each crude drug is: Radix Astragali 60g, Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Alismatis 15g, Pericarpium Citri Reticulatae 12g, Poria 12g, Semen Coicis 15g, Semen Persicae 20g, Flos Carthami 12g, Squama Manis 10g, Caulis Spatholobi 45g, Radix Notoginseng 20g, Herba Taxilli 20g, Radix Cyathulae 25g, Hirudo 20g, Ramulus Cinnamomi 15g, Radix Puerariae 20g, Cortex Eucommiae 15g, Radix Morindae Officinalis 18g, Colla cornus cervi 10g, Radix Paeoniae Alba 50g, Fructus Corni 15g, Fructus Chaenomelis 20g, Radix Saposhnikoviae 13g, Rhizoma Atractylodis 20g.
5, the described a kind of preparation method for the treatment of the medicine of paraplegia of claim 1, it is made up of following steps:
(1), the described Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis, Pericarpium Citri Reticulatae, Poria, Semen Coicis, Semen Persicae, Flos Carthami, Squama Manis, Caulis Spatholobi, Radix Notoginseng, Herba Taxilli, Radix Cyathulae, Hirudo, Ramulus Cinnamomi, Radix Puerariae, the Cortex Eucommiae, Radix Morindae Officinalis, Colla cornus cervi, the Radix Paeoniae Alba, Fructus Corni, Fructus Chaenomelis, Radix Saposhnikoviae and Rhizoma Atractylodis are pulverized, then through 100 order square-bottomed bamboo baskets screenings, carry out behind the irradiation sterilization medicine fully being stirred evenly into powder with the gamma-rays of cobalt-60;
(2), take the Mel after Coarse Mesh Gauze filters, be fried boiling with high heat, reuse slow fire is fried in shallow oil slowly, soaks buff on boiling to Mel;
(3), get in the step (1) Mel in the powder and step (2), stir evenly with 1000 gram powder and 1100 gram Mel proportionings, scoop up the bar pill with 6 gram pinch plates, paraffin paper seals, and packs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100513978A CN1308025C (en) | 2005-03-10 | 2005-03-10 | Medicine for treating paraplegia and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100513978A CN1308025C (en) | 2005-03-10 | 2005-03-10 | Medicine for treating paraplegia and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1682998A CN1682998A (en) | 2005-10-19 |
| CN1308025C true CN1308025C (en) | 2007-04-04 |
Family
ID=35262617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100513978A Expired - Fee Related CN1308025C (en) | 2005-03-10 | 2005-03-10 | Medicine for treating paraplegia and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1308025C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405649B (en) * | 2013-08-19 | 2015-05-20 | 刘建贞 | A kind of external pharmaceutical composition for rehabilitation after common peroneal nerve injury |
| CN103505531A (en) * | 2013-08-28 | 2014-01-15 | 李新民 | Traditional Chinese medicine formula for preventing and treating spondylodynia |
| CN106075116A (en) * | 2016-06-27 | 2016-11-09 | 陈中元 | A kind of medicine treating hemiplegia on the right of woman and preparation thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1181258A (en) * | 1996-10-28 | 1998-05-13 | 袁建华 | Traumatic paraplegia pills or capsules |
| CN1346675A (en) * | 2001-09-29 | 2002-05-01 | 戚晓峰 | Chinese patent medicine for treating paraplegia |
-
2005
- 2005-03-10 CN CNB2005100513978A patent/CN1308025C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1181258A (en) * | 1996-10-28 | 1998-05-13 | 袁建华 | Traumatic paraplegia pills or capsules |
| CN1346675A (en) * | 2001-09-29 | 2002-05-01 | 戚晓峰 | Chinese patent medicine for treating paraplegia |
Non-Patent Citations (1)
| Title |
|---|
| 脊髓伤方治疗胸腰椎骨折并截瘫的疗效观察 辽宁中医杂志，第31卷第1期 2004 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1682998A (en) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1286474C (en) | Medicine for treating bone wound | |
| CN1191740A (en) | Qihe fracture setting plaster with bone retaining liniment | |
| CN102935153A (en) | Qi reinforcing qianzheng pills for cerebral thrombosis disease treatment | |
| CN1091609C (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN1803187A (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN101053632A (en) | Traditional Chinese medicine for treating thromboangitis obliterans | |
| CN103417742A (en) | Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia | |
| CN103520366B (en) | Be used for the treatment of the Chinese medicine of spastic hemiplegia after stroke | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN101417003A (en) | Traditional Chinese medicine composition for treating vertebras disease | |
| CN1308025C (en) | Medicine for treating paraplegia and its preparing method | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN106177819A (en) | A kind of external medicine composition for cervical spondylosis, preparation method and applications | |
| CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN1059594C (en) | Chinese medicine Gutongning and its preparation | |
| CN1257745C (en) | Chinese medicinal composition for treating typhoid | |
| CN102100826A (en) | Chinese medicinal compound preparation for treating canine parvovirus enteritis and preparation method thereof | |
| CN1128667A (en) | Thrombus-eliminating pills | |
| CN1241580C (en) | Medicinal composition for treating hypersteogeny | |
| CN104740450A (en) | Traditional Chinese medicine foot bath powder for treating rheumatism and preparation and application method of traditional Chinese medicine foot bath powder | |
| CN104523965A (en) | Nephritis treating traditional Chinese medicine composition | |
| CN1387877A (en) | Tonic wine for resisting rheumatism and rhematoid diseases | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1059588C (en) | Method for strengthening yang |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070404 |